Skip to main content
Top
Published in: Oral Radiology 3/2017

01-09-2017 | Review Article

Basic and important points regarding the diagnosis of oral cancers using fluorine-18-labeled fluoro-2-deoxy-d-glucose positron emission tomography–computed tomography: a review

Authors: Shinji Kito, Hirofumi Koga, Masafumi Oda, Tatsurou Tanaka, Masaaki Kodama, Manabu Habu, Ikuya Miyamoto, Shinya Kokuryo, Noriaki Yamamoto, Nao Wakasugi-Sato, Shinobu Matsumoto-Takeda, Daigo Yoshiga, Kenji Osawa, Shun Nishimura, Takaaki Joujima, Ken-ichi Mochida, Noriaki Kawanabe, Kou Matsuo, Masataka Uehara, Masaaki Sasaguri, Izumi Yoshioka, Kazuhiro Tominaga, Yasuhiro Morimoto

Published in: Oral Radiology | Issue 3/2017

Login to get access

Abstract

Numerous studies, including our own, have revealed that positron emission tomography–computed tomography (PET/CT) using fluorine-18-labeled fluoro-2-deoxy-d-glucose (18F-FDG) is effective for the diagnosis of oral cancers. Large amounts of new information about primary tumors and metastatic lymph nodes have been acquired, and the use of 18F-FDG PET/CT has been shown to improve diagnostic precision in determining both the pathological characteristics of primary oral cancers and the presence of metastatic lymph nodes. However, substantial variations in 18F-FDG uptake in the oral and maxillofacial regions have been identified, and the differential diagnosis of some oral cancers and metastatic lymph nodes remains difficult for radiologists. Therefore, based on the previous research, the aim of the present study was to review the basic and important points regarding the diagnosis of primary oral cancers and metastatic lymph nodes using 18F-FDG PET/CT.
Literature
1.
go back to reference Kim SJ, Chang S. Volumetric parameters changes of sequential 18F-FDG PET/CT for early prediction of recurrence and death in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy. Clin Nucl Med. 2015;40:930–5.CrossRefPubMed Kim SJ, Chang S. Volumetric parameters changes of sequential 18F-FDG PET/CT for early prediction of recurrence and death in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy. Clin Nucl Med. 2015;40:930–5.CrossRefPubMed
2.
go back to reference Wei J, Pei S, Zhu X. Comparison of 18F-FDG PET/CT, MRI and SPECT in the diagnosis of local residual/recurrent nasopharyngeal carcinoma: a meta-analysis. Oral Oncol. 2016;52:11–7.CrossRefPubMed Wei J, Pei S, Zhu X. Comparison of 18F-FDG PET/CT, MRI and SPECT in the diagnosis of local residual/recurrent nasopharyngeal carcinoma: a meta-analysis. Oral Oncol. 2016;52:11–7.CrossRefPubMed
3.
go back to reference Müller J, Hüllner M, Strobel K, Huber GF, Burger IA, Haerle SK. The value of (18) F-FDG-PET/CT imaging in oral cavity cancer patients following surgical reconstruction. Laryngoscope. 2015;125:1861–8.CrossRefPubMed Müller J, Hüllner M, Strobel K, Huber GF, Burger IA, Haerle SK. The value of (18) F-FDG-PET/CT imaging in oral cavity cancer patients following surgical reconstruction. Laryngoscope. 2015;125:1861–8.CrossRefPubMed
4.
go back to reference Kito S, Koga H, Kodama M, Habu M, Kokuryo S, Oda M, et al. Alterations in 18F-FDG accumulation into neck-related muscles after neck dissection for patients with oral cancers. Med Oral Patol Oral Cir Bucal. 2016;21:e341–e8.CrossRefPubMedPubMedCentral Kito S, Koga H, Kodama M, Habu M, Kokuryo S, Oda M, et al. Alterations in 18F-FDG accumulation into neck-related muscles after neck dissection for patients with oral cancers. Med Oral Patol Oral Cir Bucal. 2016;21:e341–e8.CrossRefPubMedPubMedCentral
5.
go back to reference Meeuwis J, Hoekstra OS, Witte BI, Boellaard R, Leemans CR, de Bree R. 18FDG SUV in the primary tumor and lymph node metastases is not predictive for development of distant metastases in high risk head and neck cancer patients. Oral Oncol. 2015;51:536–40.CrossRefPubMed Meeuwis J, Hoekstra OS, Witte BI, Boellaard R, Leemans CR, de Bree R. 18FDG SUV in the primary tumor and lymph node metastases is not predictive for development of distant metastases in high risk head and neck cancer patients. Oral Oncol. 2015;51:536–40.CrossRefPubMed
6.
go back to reference Pasha MA, Marcus C, Fakhry C, Kang H, Kiess AP, Subramaniam RM. FDG PET/CT for management and assessing outcomes of squamous cell cancer of the oral cavity. Am J Roentgenol. 2015;205:W150–W61.CrossRef Pasha MA, Marcus C, Fakhry C, Kang H, Kiess AP, Subramaniam RM. FDG PET/CT for management and assessing outcomes of squamous cell cancer of the oral cavity. Am J Roentgenol. 2015;205:W150–W61.CrossRef
7.
go back to reference Gao S, Li S, Yang X, Tang Q. 18FDG PET-CT for distant metastases in patients with recurrent head and neck cancer after definitive treatment. A meta-analysis. Oral Oncol. 2014;50:163–7.CrossRefPubMed Gao S, Li S, Yang X, Tang Q. 18FDG PET-CT for distant metastases in patients with recurrent head and neck cancer after definitive treatment. A meta-analysis. Oral Oncol. 2014;50:163–7.CrossRefPubMed
8.
go back to reference Xu GZ, Guan DJ, He ZY. (18)FDG-PET/CT for detecting distant metastases and second primary cancers in patients with head and neck cancer. A meta-analysis. Oral Oncol. 2011;47:560–5.CrossRefPubMed Xu GZ, Guan DJ, He ZY. (18)FDG-PET/CT for detecting distant metastases and second primary cancers in patients with head and neck cancer. A meta-analysis. Oral Oncol. 2011;47:560–5.CrossRefPubMed
10.
go back to reference Kito S, Koga H, Kodama M, Yamamoto N, Kokuryo S, Habu M, et al. Reflection of 18F-FDG accumulation in the evaluation of the extent of periapical or periodontal inflammation. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114:e62–e9.CrossRefPubMed Kito S, Koga H, Kodama M, Yamamoto N, Kokuryo S, Habu M, et al. Reflection of 18F-FDG accumulation in the evaluation of the extent of periapical or periodontal inflammation. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114:e62–e9.CrossRefPubMed
11.
go back to reference Kito S, Koga H, Oda M, Tanaka T, Kodama M, Habu M, et al. The important pitfalls in the diagnosis of cancer in the oral cavity using 18F-FDG-PET-CT. In: Horizons in cancer research. Hauppague: Nova Science Publishers; 2015. pp. 85–96. Kito S, Koga H, Oda M, Tanaka T, Kodama M, Habu M, et al. The important pitfalls in the diagnosis of cancer in the oral cavity using 18F-FDG-PET-CT. In: Horizons in cancer research. Hauppague: Nova Science Publishers; 2015. pp. 85–96.
12.
go back to reference Oda M, Tanaka T, Kito S, Seta Y, Ishikawa A, Kodama M, et al. Recent advances of the diagnostic images for oral cancers. In: Oral cancer: causes, diagnosis and treatment. Hauppague: Nova Science Publishers; 2011. Oda M, Tanaka T, Kito S, Seta Y, Ishikawa A, Kodama M, et al. Recent advances of the diagnostic images for oral cancers. In: Oral cancer: causes, diagnosis and treatment. Hauppague: Nova Science Publishers; 2011.
13.
go back to reference Kowalsky RJ, Falen SW, editors. Radiopharmaceuticals in nuclear pharmacy and nuclear medicine. 2nd ed. Washington, DC: American Pharmacists Association; 2004. Kowalsky RJ, Falen SW, editors. Radiopharmaceuticals in nuclear pharmacy and nuclear medicine. 2nd ed. Washington, DC: American Pharmacists Association; 2004.
14.
go back to reference Zhuang H, Alavi A. 18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Semin Nucl Med. 2002;32:47–59.CrossRefPubMed Zhuang H, Alavi A. 18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Semin Nucl Med. 2002;32:47–59.CrossRefPubMed
15.
go back to reference Shreve PD, Bui CDH. Normal variants in FDG PET imaging. In: Wahl RL, editor. Principles and practice of positron emission tomography. Philadelphia: Lippincott Williams & Wilkins; 2002. pp. 111–36. Shreve PD, Bui CDH. Normal variants in FDG PET imaging. In: Wahl RL, editor. Principles and practice of positron emission tomography. Philadelphia: Lippincott Williams & Wilkins; 2002. pp. 111–36.
16.
go back to reference Roh JL, Ryu CH, Choi SH, Kim JS, Lee JH, Cho KJ, et al. Clinical utility of 18F-FDG PET for patients with salivary gland malignancies. J Nucl Med. 2007;48:240–6.PubMed Roh JL, Ryu CH, Choi SH, Kim JS, Lee JH, Cho KJ, et al. Clinical utility of 18F-FDG PET for patients with salivary gland malignancies. J Nucl Med. 2007;48:240–6.PubMed
17.
go back to reference Islam T, Harisinghani MG. Overview of nanoparticle use in cancer imaging. Cancer Biomark. 2009;5:61–7.CrossRefPubMed Islam T, Harisinghani MG. Overview of nanoparticle use in cancer imaging. Cancer Biomark. 2009;5:61–7.CrossRefPubMed
18.
go back to reference Lee C, Langen KM, Lu W, Haimerl J, Schnarr E, Ruchala KJ, et al. Evaluation of geometric changes of parotid glands during head and neck cancer radiotherapy using daily MVCT and automatic deformable registration. Radiother Oncol. 2008;89:81–8.CrossRefPubMed Lee C, Langen KM, Lu W, Haimerl J, Schnarr E, Ruchala KJ, et al. Evaluation of geometric changes of parotid glands during head and neck cancer radiotherapy using daily MVCT and automatic deformable registration. Radiother Oncol. 2008;89:81–8.CrossRefPubMed
19.
go back to reference Gupta T, Beriwal S. PET/CT-guided radiation therapy planning: from present to the future. Indian J Cancer. 2010;47:126–33.CrossRefPubMed Gupta T, Beriwal S. PET/CT-guided radiation therapy planning: from present to the future. Indian J Cancer. 2010;47:126–33.CrossRefPubMed
20.
go back to reference Roh JL, Yeo NK, Kim JS, Lee JH, Cho KJ, Choi SH, et al. Utility of 2-[18F] fluoro-2-deoxy-d-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma. Oral Oncol. 2007;43:887–93.CrossRefPubMed Roh JL, Yeo NK, Kim JS, Lee JH, Cho KJ, Choi SH, et al. Utility of 2-[18F] fluoro-2-deoxy-d-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma. Oral Oncol. 2007;43:887–93.CrossRefPubMed
21.
go back to reference Schwartz DL, Ford E, Rajendran J, Yueh B, Coltrera MD, Virgin J, et al. FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2005;61:129–36.CrossRefPubMed Schwartz DL, Ford E, Rajendran J, Yueh B, Coltrera MD, Virgin J, et al. FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2005;61:129–36.CrossRefPubMed
22.
go back to reference Andrade RS, Heron DE, Degirmenci B, Filho PA, Branstetter BF, Seethala RR, et al. Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers. Int J Radiat Oncol Biol Phys. 2006;65:1315–22.CrossRefPubMed Andrade RS, Heron DE, Degirmenci B, Filho PA, Branstetter BF, Seethala RR, et al. Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers. Int J Radiat Oncol Biol Phys. 2006;65:1315–22.CrossRefPubMed
23.
go back to reference Suzuki H, Fukuyama R, Hasegawa Y, Tamaki T, Nishio M, Nakashima T, et al. Tumor thickness, depth of invasion, and Bcl-2 expression are correlated with FDG-uptake in oral squamous cell carcinomas. Oral Oncol. 2009;45:891–7.CrossRefPubMed Suzuki H, Fukuyama R, Hasegawa Y, Tamaki T, Nishio M, Nakashima T, et al. Tumor thickness, depth of invasion, and Bcl-2 expression are correlated with FDG-uptake in oral squamous cell carcinomas. Oral Oncol. 2009;45:891–7.CrossRefPubMed
24.
go back to reference Chung MK, Jeong HS, Son YI, So YK, Park GY, Choi JY, et al. Metabolic tumor volumes by [18F]-fluorodeoxyglucose PET/CT correlate with occult metastasis in oral squamous cell carcinoma of the tongue. Ann Surg Oncol. 2009;16:3111–7.CrossRefPubMed Chung MK, Jeong HS, Son YI, So YK, Park GY, Choi JY, et al. Metabolic tumor volumes by [18F]-fluorodeoxyglucose PET/CT correlate with occult metastasis in oral squamous cell carcinoma of the tongue. Ann Surg Oncol. 2009;16:3111–7.CrossRefPubMed
25.
go back to reference Miyawaki A, Ikeda R, Hijioka H, Ishida T, Ushiyama M, Nozoe E, et al. SUVmax of FDG-PET correlates with the effects of neoadjuvant chemoradiotherapy for oral squamous cell carcinoma. Oncol Rep. 2010;23:1205–12.CrossRefPubMed Miyawaki A, Ikeda R, Hijioka H, Ishida T, Ushiyama M, Nozoe E, et al. SUVmax of FDG-PET correlates with the effects of neoadjuvant chemoradiotherapy for oral squamous cell carcinoma. Oncol Rep. 2010;23:1205–12.CrossRefPubMed
26.
go back to reference Suzuki H, Hasegawa Y, Terada A, Hyodo I, Nakashima T, Nishio M, et al. FDG-PET predicts survival and distant metastasis in oral squamous cell carcinoma. Oral Oncol. 2009;45:569–73.CrossRefPubMed Suzuki H, Hasegawa Y, Terada A, Hyodo I, Nakashima T, Nishio M, et al. FDG-PET predicts survival and distant metastasis in oral squamous cell carcinoma. Oral Oncol. 2009;45:569–73.CrossRefPubMed
27.
go back to reference Kubota K, Yokoyama J, Yamaguchi K, Ono S, Qureshy A, Itoh M, et al. FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT. Eur J Nucl Med Mol Imaging. 2004;31:590–5.CrossRefPubMed Kubota K, Yokoyama J, Yamaguchi K, Ono S, Qureshy A, Itoh M, et al. FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT. Eur J Nucl Med Mol Imaging. 2004;31:590–5.CrossRefPubMed
28.
go back to reference Krabbe CA, Pruim J, Dijkstra PU, Balink H, van der Laan BF, de Visscher JG, et al. 18F-FDG PET as a routine posttreatment surveillance tool in oral and oropharyngeal squamous cell carcinoma: a prospective study. J Nucl Med. 2009;50:1940–7.CrossRefPubMed Krabbe CA, Pruim J, Dijkstra PU, Balink H, van der Laan BF, de Visscher JG, et al. 18F-FDG PET as a routine posttreatment surveillance tool in oral and oropharyngeal squamous cell carcinoma: a prospective study. J Nucl Med. 2009;50:1940–7.CrossRefPubMed
29.
go back to reference McGarvey AC, Osmotherly PG, Hoffman GR, Chiarelli PE. Scapular muscle exercises following neck dissection surgery for head and neck cancer: a comparative electromyographic study. Phys Ther. 2013;93:786–97.CrossRefPubMed McGarvey AC, Osmotherly PG, Hoffman GR, Chiarelli PE. Scapular muscle exercises following neck dissection surgery for head and neck cancer: a comparative electromyographic study. Phys Ther. 2013;93:786–97.CrossRefPubMed
30.
go back to reference McGarvey AC, Osmotherly PG, Hoffman GR, Chiarelli PE. Impact of neck dissection on scapular muscle function: a case-controlled electromyographic study. Arch Phys Med Rehabil. 2013;94:113–9.CrossRefPubMed McGarvey AC, Osmotherly PG, Hoffman GR, Chiarelli PE. Impact of neck dissection on scapular muscle function: a case-controlled electromyographic study. Arch Phys Med Rehabil. 2013;94:113–9.CrossRefPubMed
31.
go back to reference McGarvey AC, Chiarelli PE, Osmotherly PG, Hoffman GR. Physiotherapy for accessory nerve shoulder dysfunction following neck dissection surgery: a literature review. Head Neck. 2011;33:274–80.CrossRefPubMed McGarvey AC, Chiarelli PE, Osmotherly PG, Hoffman GR. Physiotherapy for accessory nerve shoulder dysfunction following neck dissection surgery: a literature review. Head Neck. 2011;33:274–80.CrossRefPubMed
32.
go back to reference Andreadis D, Stylianou F, Link-Tsatsouli I, Markopoulos A. Bilateral masseter and internal pterygoid muscle hypertrophy: a diagnostic challenge. Med Princ Pract. 2014;23:286–8.CrossRefPubMed Andreadis D, Stylianou F, Link-Tsatsouli I, Markopoulos A. Bilateral masseter and internal pterygoid muscle hypertrophy: a diagnostic challenge. Med Princ Pract. 2014;23:286–8.CrossRefPubMed
33.
go back to reference Ariji Y, Fuwa N, Kodaira T, Tachibana H, Nakamura T, Satoh Y, et al. False-positive positron emission tomography appearance with 18F-fluorodeoxyglucose after definitive radiotherapy for cancer of the mobile tongue. Br J Radiol. 2009;82:e3–e7.CrossRefPubMed Ariji Y, Fuwa N, Kodaira T, Tachibana H, Nakamura T, Satoh Y, et al. False-positive positron emission tomography appearance with 18F-fluorodeoxyglucose after definitive radiotherapy for cancer of the mobile tongue. Br J Radiol. 2009;82:e3–e7.CrossRefPubMed
34.
go back to reference Bogsrud TV, Lowe VJ. Normal variants and pitfalls in whole-body PET imaging with 18F FDG. Appl Radiol.0. 2006;35:16–30. Bogsrud TV, Lowe VJ. Normal variants and pitfalls in whole-body PET imaging with 18F FDG. Appl Radiol.0. 2006;35:16–30.
35.
go back to reference Shimamoto H, Tatsumi M, Kakimoto N, Hamada S, Shimosegawa E, Murakami S, et al. (18)F-FDG accumulation in the oral cavity is associated with periodontal disease and apical periodontitis: an initial demonstration on PET/CT. Ann Nucl Med. 2008;22:587–93.CrossRefPubMed Shimamoto H, Tatsumi M, Kakimoto N, Hamada S, Shimosegawa E, Murakami S, et al. (18)F-FDG accumulation in the oral cavity is associated with periodontal disease and apical periodontitis: an initial demonstration on PET/CT. Ann Nucl Med. 2008;22:587–93.CrossRefPubMed
36.
go back to reference Abdoli M, Ay MR, Ahmadian A, Zaidi H. A virtual sinogram method to reduce dental metallic implant artefacts in computed tomography-based attenuation correction for PET. Nucl Med Commun. 2010;31:22–31.CrossRefPubMed Abdoli M, Ay MR, Ahmadian A, Zaidi H. A virtual sinogram method to reduce dental metallic implant artefacts in computed tomography-based attenuation correction for PET. Nucl Med Commun. 2010;31:22–31.CrossRefPubMed
37.
go back to reference Kamel EM, Burger C, Buck A, von Schulthess GK, Goerres GW. Impact of metallic dental implants on CT-based attenuation correction in a combined PET/CT scanner. Eur Radiol. 2003;13:724–8.CrossRefPubMed Kamel EM, Burger C, Buck A, von Schulthess GK, Goerres GW. Impact of metallic dental implants on CT-based attenuation correction in a combined PET/CT scanner. Eur Radiol. 2003;13:724–8.CrossRefPubMed
38.
go back to reference Harnsberger HR. Handbook of head and neck imaging. 2nd ed. St. Louis: Mosby-Year Book, Inc; 1994. Harnsberger HR. Handbook of head and neck imaging. 2nd ed. St. Louis: Mosby-Year Book, Inc; 1994.
39.
go back to reference Morimoto Y, Tanaka T, Yamamoto N, Kodama M, Seta Y, Habu M, et al. New trends and advances in oral and maxillofacial imaging. Curr Med Imaging Rev. 2009;5:226–37.CrossRef Morimoto Y, Tanaka T, Yamamoto N, Kodama M, Seta Y, Habu M, et al. New trends and advances in oral and maxillofacial imaging. Curr Med Imaging Rev. 2009;5:226–37.CrossRef
40.
go back to reference Liao CT, Wang HM, Chang JT, Lin CY, Ng SH, Huang SF, et al. Influence of pathological nodal status and maximal standardized uptake value of the primary tumor and regional lymph nodes on treatment plans in patients with advanced oral cavity squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2010;77:421–9.CrossRefPubMed Liao CT, Wang HM, Chang JT, Lin CY, Ng SH, Huang SF, et al. Influence of pathological nodal status and maximal standardized uptake value of the primary tumor and regional lymph nodes on treatment plans in patients with advanced oral cavity squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2010;77:421–9.CrossRefPubMed
41.
go back to reference Liao CT, Chang JT, Wang HM, Ng SH, Huang SF, Chen IH, et al. Preoperative [18F]-fluorodeoxyglucose positron emission tomography standardized uptake value of neck lymph nodes may aid in selecting patients with oral cavity squamous cell carcinoma for salvage therapy after relapse. Eur J Nucl Med Mol Imaging. 2009;36:1783–93.CrossRefPubMed Liao CT, Chang JT, Wang HM, Ng SH, Huang SF, Chen IH, et al. Preoperative [18F]-fluorodeoxyglucose positron emission tomography standardized uptake value of neck lymph nodes may aid in selecting patients with oral cavity squamous cell carcinoma for salvage therapy after relapse. Eur J Nucl Med Mol Imaging. 2009;36:1783–93.CrossRefPubMed
42.
go back to reference Goerres GW, Schmid DT, Grätz KW, von Schulthess GK, Eyrich GK. Impact of whole body positron emission tomography on initial staging and therapy in patients with squamous cell carcinoma of the oral cavity. Oral Oncol. 2003;39:547–51.CrossRefPubMed Goerres GW, Schmid DT, Grätz KW, von Schulthess GK, Eyrich GK. Impact of whole body positron emission tomography on initial staging and therapy in patients with squamous cell carcinoma of the oral cavity. Oral Oncol. 2003;39:547–51.CrossRefPubMed
Metadata
Title
Basic and important points regarding the diagnosis of oral cancers using fluorine-18-labeled fluoro-2-deoxy-d-glucose positron emission tomography–computed tomography: a review
Authors
Shinji Kito
Hirofumi Koga
Masafumi Oda
Tatsurou Tanaka
Masaaki Kodama
Manabu Habu
Ikuya Miyamoto
Shinya Kokuryo
Noriaki Yamamoto
Nao Wakasugi-Sato
Shinobu Matsumoto-Takeda
Daigo Yoshiga
Kenji Osawa
Shun Nishimura
Takaaki Joujima
Ken-ichi Mochida
Noriaki Kawanabe
Kou Matsuo
Masataka Uehara
Masaaki Sasaguri
Izumi Yoshioka
Kazuhiro Tominaga
Yasuhiro Morimoto
Publication date
01-09-2017
Publisher
Springer Singapore
Published in
Oral Radiology / Issue 3/2017
Print ISSN: 0911-6028
Electronic ISSN: 1613-9674
DOI
https://doi.org/10.1007/s11282-017-0273-0

Other articles of this Issue 3/2017

Oral Radiology 3/2017 Go to the issue